Sun Pharma to buy Organon in $11.75 billion all-cash dealSun Pharmaceutical Industries has agreed to acquire U.S. drugmaker Organon & Co in an all-cash deal valued at approximately $11.75 billion,...
27 Apr, 2026, 06.55 AM IST
Sun Pharma looks to outshine rival bids with $13 billion Organon offerSun Pharmaceutical is making its biggest move yet with a $13 billion offer for Organon & Co. This ambitious bid aims to transform the India...
24 Apr, 2026, 08.17 AM IST
Merck braces for Keytruda patent loss with $6.7 billion Terns betMerck is acquiring Terns Pharma for $6.7 billion to strengthen its cancer drug pipeline, aiming to reduce reliance on its blockbuster Keytr...
26 Mar, 2026, 01.13 AM IST
Verona Pharma stock jumps 20% on $10B Merck deal—can FDA-approved Ohtuvayre reshape COPD care?Verona Pharma stock jumped 20% after Merck announced it will acquire the British biotech in a $10 billion deal. Merck will pay $107 per sha...
09 Jul, 2025, 06.39 PM IST
Merck nears $10 bn deal for respiratory drugmaker Verona: ReportsMerck is close to buying Verona Pharma, a biotech firm specializing in lung diseases. The deal is valued at around $10 billion. Merck aims ...
09 Jul, 2025, 02.59 PM IST
Merck Ltd renamed as Procter & Gamble Health LtdThe consumer health business was transferred to P&G on December 1, 2018, it added.
07 May, 2019, 02.29 PM IST
CCI approves P&G's stake acquisition in MerckThe global deal is for about 3.4 billion euro in cash.
07 Aug, 2018, 06.13 PM IST
- Merck to acquire SmartCells for USD 500 mn
Drug-maker Merck & Co has announced that it will buy biotechnology company SmartCells for USD 500 million.
03 Dec, 2010, 11.00 PM IST
- Merck to take buyout route to grow here
The world’s second-biggest drugmaker, Merck & Co, is looking at acquisitions and alliances with local firms to scale up its business in Ind...
15 Nov, 2010, 01.28 AM IST
- Drugmaker Merck closing 8 plants, 8 research sites
Drugmaker Merck & Co. said Thursday it is shutting down eight manufacturing plants and eight research sites around the world, including two...
08 Jul, 2010, 07.45 PM IST
- Merck KGaA acquires Bangalore-based bioscience company
Merck KGaA today announced the acquisition of Bangalore Genei (India) Private Limited by its wholly-owned subsidiary in India, Merck Specia...
13 Oct, 2009, 02.14 PM IST
- Merck buys Schering-Plough in $41.1b cash-&-stock deal
US-based Merck & Co is acquiring Schering-Plough for $41.1 billion in a cash-and-stock deal, to create a $47 billion drug major.
10 Mar, 2009, 10.27 AM IST
- Merck buys Schering-Plough for $41 bn to access new drugs
US-based Merck & Co on Monday said it is acquiring Schering Plough for $41.1 bn in a cash-and-stock deal to create a $42-bn drug major.
10 Mar, 2009, 03.10 AM IST
- Mylan Labs may use Indian platform for global pharma play
With the acquisition of Merck KGaA’s generic business by Mylan Laboratories, India is set to become a major manufacturing hub for the US dr...
14 May, 2007, 12.27 AM IST
- Ranbaxy sees synergy dose in Merck unit
Ranbaxy’s reported interest in the Merck KGaA’s generic division has the potential of being one of the most synergistic acquisitions in rec...
10 Jan, 2007, 12.41 AM IST
- Merck buy may give Ranbaxy access to US, Europe markets
Ranbaxy Labs has joined the race with global pharma companies such as Teva, Novartis and Sanofi-Aventis for acquiring the global generic dr...
09 Jan, 2007, 02.14 AM IST
- Ranbaxy may pop Merck pill
Ranbaxy Labs has entered the race for acquiring the global generic drug business of Merck KGaA.
09 Jan, 2007, 01.56 AM IST